|
You are here: Home: BCU 2|2004: Faculty Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
|
| I Craig Henderson, MD, FACP, FRCP |
Stock Shareholder: Johnson & Johnson Pharmaceuticals
Honorarium: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Novartis Pharmaceuticals, Pfizer Inc, Roche Laboratories Inc |
| Anthony Howell, MD, MSc, FRCP |
No financial interests or affiliations to disclose |
| Julie R Gralow, MD |
Grants/Research Support and Consultant: Amgen Inc, Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company, Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals, Ortho Biotech Products LP Honorarium: Amgen Inc, AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company, Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals, Ortho Biotech Products LP, Pfizer Inc |
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
|
|
